title: Chemical Pleurodesis Using Mistletoe Extraction (ABNOVAviscum(®) Injection) for Malignant Pleural Effusion.
abstract: OBJECTIVE
  Malignant pleural effusion (MPE) is common in patients with advanced cancer. Chemical pleurodesis can be considered for MPE that do not respond to chemotherapy, radiotherapy, or therapeutic thoracentesis. However, it is not yet clear which agent is more effective and safer in chemical pleurodesis.
  
  
  METHODS
  This study was designed as a single arm, multicenter, and open-label phase III clinical trial to evaluate efficacy and safety of chemical pleurodesis using mistletoe extraction (ABNOVAviscum(®) Injection). References of other agents in chemical pleurodesis were investigated to compare efficacy and safety. Efficacy was evaluated by followed up chest X-ray and changes of clinical symptoms and Karnofsky performance scale. Safety was evaluated by serious adverse event (SAE) and changes of laboratory findings. A follow-up period was 4 weeks after last pleurodesis.
  
  
  RESULTS
  Of 62 patients, 49 (79.0%) had complete response, 11 (17.7%) had partial response, and two had no response. Mean response rate was significantly different in this study comparing with reference response rate which was 64% (p <0.0001). There were two SAEs, but all were recovered without sequelas.
  
  
  CONCLUSIONS
  The results of this study suggest that mistletoe extraction (ABNOVAviscum(®) Injection) could be an effective and safe agent of chemical pleurodesis in patients with MPE.
authors.affiliation: Department of Thoracic and Cardiovascular Surgery, Pusan National University Hospital, Medical Research Institution, Busan, Republic of Korea.
authors.forename: Jeong Su
authors.initials: JS
authors.lastname: Cho
authors.forename: Kook Joo
authors.initials: KJ
authors.lastname: Na
authors.forename: Yongjik
authors.initials: Y
authors.lastname: Lee
authors.forename: Yeong Dae
authors.initials: YD
authors.lastname: Kim
authors.forename: Hyo Yeong
authors.initials: HY
authors.lastname: Ahn
authors.forename: Chang Ryul
authors.initials: CR
authors.lastname: Park
authors.forename: Young Chul
authors.initials: YC
authors.lastname: Kim
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D017567:Karnofsky Performance Status; D008297:Male; D008875:Middle Aged; D014784:Mistletoe / Q000737:chemistry; D008517:Phytotherapy; D010936:Plant Extracts / Q000008:administration & dosage* / Q000009:adverse effects / Q000302:isolation & purification; D010946:Plants, Medicinal; D016066:Pleural Effusion, Malignant / Q000175:diagnosis / Q000628:therapy*; D018700:Pleurodesis / Q000009:adverse effects / Q000379:methods*; D012074:Remission Induction; D056910:Republic of Korea; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D010936:Plant Extracts